Fewer Public Biotechs in 2010 vs 2008

Fewer Public Biotechs in 2010 vs 2008

Back in January 2008, we were tracking 394 “active” public biotech companies. (By “active”, we mean companies that are filing with the SEC and not in bankruptcy or in a major restructuring due financial distress.) As of January 2010, we have 295 – a loss of ~25%.

About 48% of the companies that are no longer “active” have been acquired and 52% have gone out of business, filed bankruptcy, or are no longer filing with the SEC. The 295 number includes the addition of 3 IPOs in 2009, and the addition of a few companies that came out of bankruptcy in 2009.

Filed under: Inside BIO Industry Analysis, ,